Keyi Jia

<p>OX40 (CD134) and OX40 ligand, important immune checkpoints in cancer</p>

Juan Deng, Sha Zhao, Xiaoshen Zhang et al. · OncoTargets and Therapy · 2019 · 84 citations · Full text

Medicine, Immunology, Oncology +12

Anti-tumor efficacy of HRS-4642 and its potential combination with proteasome inhibition in KRAS G12D-mutant cancer

Caicun Zhou, Chongyang Li, Libo Luo et al. · Cancer Cell · 2024 · 81 citations

Medicine, Medicinal Chemistry, Oncology +13

PD-L1 methylation restricts PD-L1/PD-1 interactions to control cancer immune surveillance

Changsheng Huang, Shengxiang Ren, Yaqi Chen et al. · Science Advances · 2023 · 64 citations · Full text

Medicine, Cancer Biology, Oncology +17

OX40 and OX40L protein expression of tumor infiltrating lymphocytes in non-small cell lung cancer and its role in clinical outcome and relationships with other immune biomarkers

Yayi He, Xiaoshen Zhang, Keyi Jia et al. · Translational Lung Cancer Research · 2019 · 54 citations · Full text

Medicine, Immunology, Oncology +17

Galectin-9 in non-small cell lung cancer

Yayi He, Keyi Jia, Rafał Dziadziuszko et al. · Lung Cancer · 2019 · 50 citations

Medicine, Cancer Biology, Oncology +12